Radiation dose in Hodgkin's disease: Are we overtreating?

This publication has 21 references indexed in Scilit:

• ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
  Journal of Clinical Oncology, 1994
• A re-analysis of available dose-response and time-dose data in Hodgkin's disease
  Radiotherapy and Oncology, 1994
• Efficacy and toxicity of vinblastine, bleomycin, and methotrexate with involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: a British National Lymphoma Investigation pilot study.
  Journal of Clinical Oncology, 1994
• Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
  Journal of Clinical Oncology, 1993
• An updated dose-response analysis in Hodgkin's disease
  Radiotherapy and Oncology, 1992
• Improved survival in advanced Hodgkin's disease with the use of combined modality therapy
  International Journal of Radiation Oncology*Biology*Physics, 1990
• Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease
  International Journal of Radiation Oncology*Biology*Physics, 1988
• REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX
  The Lancet, 1985
• The place of radiotherapy in the management of localised Hodgkin's disease (report no 11)
  Clinical Radiology, 1981
• Hodgkin's disease, stages I and II.Relationship of recurrence to size of disease, radiation dose, and number of sites involved
  Cancer, 1979